Roundhill China Dragons ETF

BYD's third-generation Yuan PLUS will be launched on May 21

Over 10 car companies, including BYD, have raised prices on some models

BYD sales in China slow as overseas deliveries skyrocket

China's Auto Patents Surge, BYD's Quarterly R&D Expenses Exceed 10 Billion Yuan

BYD launches three new energy vehicles in Bangladesh

BYD Executive Responds to Doubts Over Singular Battery Technology Route, Stating Multiple Routes Are Being Developed Simultaneously

BYD launches new intelligent in-car radio with off-grid communication support

BYD's Fang Cheng Bao 'Leopard' Smart Charging Pile Relaunched

BYD, Mercedes, and Red Bull Consortium Bid for Alpine Team Shares and Engine Plant

Pop Star Wang Leehom Confirms Entire Denza Endorsement Fee Was Used to Purchase BYD Stock

BYD Executive Confirms Talks with Stellantis and Other Carmakers to Acquire Idle European Factories

BYD and other auto giants discuss the future of smart mobility in Thailand

A shipment of nearly 5,000 BYD vehicles is heading to Australia to meet growing local demand for electric and plug-in hybrid vehicles.

People's Daily Explores the 'Talent Code' of the New Energy Vehicle Industry, Citing BYD as an Example

BYD Executive Responds to 'Flash Charging Damages Battery' Concerns

BYD's Fang Cheng Bao 'Bao 3' Flash Charging Edition Models Begin Normal Delivery

BYD confirms the launch of its first seven-seater plug-in hybrid SUV, the Ti7, for the UK market

BYD SHARK Pickup to Launch in China in the Second Half of 2026

BYD postpones flagship electric SUV launch due to over 100,000 pre-orders

BYD delays flagship SUV 'Datang' launch due to surging demand, bookings exceed 100k

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

MCHI

DRAG

Global central banks' use of the People's Bank of China's (PBOC) swap lines reached a two-year high in Q1, with 111.6 billion yuan drawn, marking a 17.4 billion yuan increase from the previous quarter. This rise indicates growing international demand for the renminbi and highlights China's efforts for currency internationalization. As of 2025, China has established swap lines with 32 countries, totaling 4.52 trillion yuan, reflecting a shift towards reducing reliance on the US dollar.

- In the first quarter, global central banks utilized the People's Bank of China's (PBOC) swap line, reaching the highest level in two years, indicating rising demand for the yuan.  
- By the end of March, central banks had borrowed a total of 111.6 billion yuan (approximately 21 billion SGD) from the PBOC's foreign exchange swap, marking a quarterly increase of 17.4 billion yuan, the largest since 2023.  
- This surge highlights China's efforts to internationalize the yuan as countries increasingly seek to reduce their reliance on the US dollar.

Businesstimes News

iShares MSCI China

ETFS Physical Renminbi ETF

Invesco Golden Dragon China

Global central banks’ use of reminbi swap lines hits 2‑year high amid rising demand for China’s currency

China's National Bureau of Statistics reported that the Consumer Price Index (CPI) rose 1.2% year-on-year in April, surpassing the forecast of 0.9%. Urban prices increased by 1.2%, while rural prices rose by 1%. Food prices fell by 1.6%, but non-food prices increased by 1.8%. Month-on-month, the CPI rose 0.3%. Notably, prices in the food, tobacco, and alcohol category fell 0.8% YoY, impacting the CPI negatively. Overall, six out of seven major categories saw YoY price increases, with transportation and communication rising by 11%.

- In April, China's Consumer Price Index (CPI) rose by 1.2% year-on-year, exceeding market expectations of 0.9%.  
- Urban prices increased by 1.2%, while food prices decreased by 1.6%, and non-food prices rose by 1.8%.  
- Monthly CPI saw a 0.3% increase, driven by higher service prices, despite declines in certain food categories such as pork and vegetables.

AASTOCKS News

China Apr CPI Rises 1.2% YoY, Above 0.9% Forecast

.HXC

China's factory-gate prices rose for the second consecutive month in April, with the producer price index (PPI) increasing by 2.8% year-on-year, surpassing economists' expectations of 1.7%. This rise follows a prolonged deflationary period. The consumer price index (CPI) also saw a year-on-year increase of 1.2%, driven by higher global oil prices and increased travel demand. Food prices fell by 1.6%, while non-food prices rose by 1.8%. Overall, the data indicates a shift in inflation trends in China amid ongoing geopolitical tensions.

NASDAQ Golden Dragon China Index

China factory-gate prices rise for second straight month

Independent refiners in China's Shandong province are reducing fuel output due to declining margins and weak domestic demand, despite a directive from Beijing to maintain production. The average operating rate has dropped to around 50% from 55% in April, with some refiners facing losses of 500 to 600 yuan per tonne processed. The situation is exacerbated by high crude prices following the Iran war and a domestic supply glut. Some refiners have requested permission to lower processing rates or suspend operations, but approval from Beijing is still pending.

China’s independent refiners cut output in May as losses mount: sources

China's factory prices rose 2.8% in April, the fastest since the pandemic, driven by rising costs from the Iran war. Despite a slump in food prices, consumer inflation unexpectedly increased to 1.2%. The conflict has pressured profits as companies struggle with higher costs amid weak domestic demand. While exports remain resilient, the economic impact of the war is expected to be a key topic in upcoming talks between US President Trump and Chinese leader Xi Jinping. Analysts warn that while inflation pressures are rising, sustained reflation remains uncertain due to overcapacity and sluggish demand.

- China's producer prices grew 2.8% in April, the fastest increase since July 2022, driven by the impact of the Iran war and rising commodity costs.  
- Despite a drop in food prices, consumer inflation unexpectedly rose to 1.2%, with significant contributions from higher fuel and gold prices.  
- Economic pressures from the Middle East conflict are expected to be central in discussions between US President Trump and Chinese leader Xi Jinping, affecting China's economic policies and inflation outlook.

Straitstimes

China’s factory inflation hits post-Covid high on Iran war cost shock

YANG

China's April inflation data is expected today, following a surge in exports of 14.1% due to global stockpiling amid the Iran war. Analysts forecast the Consumer Price Index (CPI) to be around 0.8% to 1.0% year-on-year, slightly down from March's 1.0%. Core CPI is expected to remain between 1.1% and 1.2%, indicating weak domestic demand. The Producer Price Index (PPI) is projected to rise to 1.5% to 1.9% year-on-year, reflecting increased energy and commodity costs. The divergence between CPI and PPI will be crucial for market dynamics.

- In April, China’s export surged by 14.1% due to global stockpiling concerns stemming from the war in Iran.  
- Analysts predict that the Consumer Price Index (CPI) for April will be around 0.8% to 1.0%, reflecting a slight slowdown from March, while the Producer Price Index (PPI) is expected to rise between 1.5% and 1.9%, influenced by increasing energy and commodity costs.  
- The divergence between softening CPI and strengthening PPI will be a key focus for markets, highlighting the uneven nature of price recovery in China.

Investinglive

Direxion FTSE China Bear 3X

iShares China Large Cap

Economic and event calendar in Asia Monday, May 11, 2026 - China inflation data

China will grant up to two years of market exclusivity to manufacturers of eligible innovative pediatric drugs to boost R&D in pediatric medicines. The new policy, issued by the National Health Commission and other ministries, also introduces patent term compensations and aims to support the development of treatments for common childhood diseases and rare diseases. Regulators will assist in improving drug development efficiency and prioritize registration applications for innovative pediatric drugs. Additionally, the government will explore a national pediatric clinical trial network and support the development of commercial insurance products for children.

Yicai

China to Give Innovative Pediatric Drugmakers Market Exclusivity of Up to Two Years

.IXIC

NDAQ

QQQM

ONEQ

The Chinese Embassy in the U.S. outlined four critical issues that should not be discussed during President Trump's meeting with President Xi Jinping: Taiwan, democracy and human rights, political systems, and China's development rights. The meeting will also cover the Iran war, trade, and U.S. arms sales to Taiwan, amidst bipartisan pressure for Trump to address these topics. Additionally, discussions on economic partnerships and a potential extension of a trade truce are expected, following previous tensions due to tariffs.

- The Chinese Embassy in the U.S. outlined four contentious issues, referred to as “red lines,” that should not be discussed in the upcoming meeting between Presidents Trump and Xi, including Taiwan, human rights, political systems, and China's development rights.  
- The meeting will address significant topics such as U.S. arms sales to Taiwan, the Iran war, and potential economic partnerships, following previous tensions from Trump's tariffs.  
- President Trump expressed bipartisan pressure to address Taiwan's support, alongside calls for human rights discussions, emphasizing the strategic relationship between the two superpowers.

Thehill

NASDAQ Composite Index

Nasdaq

Invesco Nasdaq 100 ETF

Fidelity Nasdaq Composite Index ETF

Invesco QQQ Trust

Chinese Embassy posts ‘red lines’ that should not be challenged in Trump, Xi talks

Concerns are rising that President Trump's visit to China may not yield a breakthrough in the Iran conflict, potentially leading to renewed U.S. military action. Investors are wary as the U.S.-China summit focuses on economic issues, with little expectation of Chinese intervention in Iran. Analysts suggest that if no progress is made, market volatility could increase next week, especially if Trump feels politically supported to escalate military actions. The stock market has been strong recently, but risks related to the Iran situation could emerge soon after Trump's return from China.

Dow Jones

Macquarie Group Limited

Tesla

NVIDIA

S&P 500

NVIDIA Corporation

Trump's China visit could rattle markets if it doesn't bring an Iran breakthrough

President Trump arrived in China for a crucial meeting with President Xi Jinping, accompanied by a group of influential CEOs from major U.S. companies, representing a combined market capitalization of approximately $16.4 trillion. Trump aims to negotiate for greater market access and reduced trade barriers, emphasizing the need for U.S. businesses to operate more freely in China. The visit highlights ongoing tensions between the U.S. and China over tariffs and technology restrictions, with a focus on fostering business relations.

benzinga_article

Apple

BlackRock

Blackstone

Boeing

Citigroup

Coherent Corp.

GE Aerospace

Goldman Sachs

Illumina

Mastercard

Meta Platforms

Micron Tech

Qualcomm

Visa

Alphabet

Alphabet - C

Marvell Tech

Rocket Lab

BlackRock Tech and Private Equity Term Trust

BLACKROCK MULTI-SECTOR INCOME TR COM USD0.001(S/R 09/09/2025) WI

Blackrock Enhanced Div Achievers Trust

BlackRock Science and Tech Term Trust

BlackRock Multi-Sector Income Trust

Boeing Company

CITIGROUP INC 6.250 NON CUM SER II PFD WI

GS Hldg R

Trump Lands In China With $16 Trillion Of CEO Power — And One Big Ask For Xi

Roundhill China Dragons ETF(DRAG.US)